Classic prognostic markers in breast cancer include tumor size, histologic grade (HG), estrogen receptor (ER), and progesterone receptor (PR), Ki67 proliferation index, human epidermal growth factor receptor type 2 (HER2) protein and axillary lymph node (N) status. This evidence concerns the gene ERBB2 and breast carcinoma.